Author: Nu-living

I just came back from Las Vegas where I attended the annual meeting of the A4M which stands for the American Academy of Antiaging and Restorative Medicine.  Prior to the conference, I attended two workshops. One workshop was Reversing Physical Aging with Hormone Therapies and the other was Peptide Therapy. The first workshop reviewed the characteristics of aging of the various organs and systems of the body and how they related to various hormone deficiencies which develop with aging. The main focus was on testosterone, growth hormone, IGF-I, Thymosin–alpha–1 and Insulin.

The peptide workshop was all about using growth hormone releasing hormones (GHRH), growth hormone secretagogues (GHRP), and various fragments of growth hormone and IGF-I (insulin-like growth factor). These peptides which are small proteins consisting of amino acids usually less than 50, can do much to restore muscle mass, reduce body fat, improved endurance, improved brain function, improved immune system, improved bone, and counter many of the chronic problems associated with aging. Peptides have become very specialized and some are now being used to facilitate healing, increased libido the sexual function and med women, stimulate stem cells and restorative joint function. I have already been prescribing peptide therapy using Sermorelin, however, there are now new peptides such as Ipamorelin which provide additional benefits.

While the concept of antiaging sometimes seems to be wishful thinking, is basically the ideas embodied in the NIH sponsored Precision Medicine Initiative, which you can learn more about here. Precision Medicine is a powerful tool integrating complex health data into actionable guidance and personalized intervention to improve individual health. The process involves detecting potential health problems both present and in the future, predicting health conditions based on lifestyle and genetics, reversing the impact of genetic, lifestyle and metabolic problems and helping patients understand her own health destiny.

New services and features which will be available in my practice will include telomere testing, metabolomics, improved methods to recommend supplements, advanced hormone therapy and expanded Peptide therapy.

Hello from beautiful Philadelphia where I am Menopause  the annual meeting of the 2017 North American Menopause Society or the NAMS. NAMS is a leading organization in  the area of women’s health . On Wednesday , I attended an all day session on diagnosis and up to date treatment  osteoporosis . There are new approaches and new medicines to learn about . Many of the top doctors and researchers from the ASBRM ( American Society of Bone and Mineral Health) and the NOF (National Osteoporosis Foundation) lectured at the meeting . These international thought leaders were available to talk with physicians like myself who attended the meeting . It was a wonderful educational opportunity for me . Moreover, my patients will directly benefit from what I learned.

On Thursday , the newest NAMS recommendations on the use, value and safety  of hormones was introduced and discussed. There is so much misinformation being provided to women who should be on hormones because of the failure of the medical community in general to keep up with developments for the past 18 years! It is estimated that 75, 000 osteoporotic bone fracture occur each year because women have been made fearful of hormone use.

I also learned about the newest data, in preventing coronary heart disease  and reducing  mortality  with hormone therapy  in young postmenopausal  women. Presently , I am listening to an excellent presentation on migraine in women . More to come……

Having returned from Orlando where the annual meeting of the Age Management Medical Group  has just ended, I was impressed by several presentations. The safety of testosterone replacement in hypogonadal men has recently been raised by two studies over the past 2 years. Before these concerning studies , there had been many positive studies supporting the benefit of middle age and elderly men using testosterone. While both of these recent studies have been critized for poor methodolgy of study design , their combined impact has caused some physicans and the FDA to caution patients about potential adverse  cardiovascular events in older men using testosterone. There are now 4 new studies reported this year  , small in scope, but nevertheless  reassuring that testosterone use is not a cardiovascular risk for men who use it. . I will publish the details in a news article in a few days.

Endo 2015 also had news for women concerninfg the use of hormone replacement therapy and it was also good. A large meta-analysis  looking at the mortality data of women who have used hormone replacement therapy has found no difference in mortality . For those women  who use hormones after menopause for “quality of life ” reasons this is very reassuring . I will also discuss this study in detail in anothger news article.

I have been to the American Academy of Anti-aging and Restorative Medicine in Las Vegas in December 2014 and now the Age Mangement Medical Group and the themes at both meeting stress the emerging topic of how clinical genomics, nutrition , hormone balance, detoxification promote healthy aging. More comments on this to follow.